Lineage Cell Therapeutics, Inc. (LCTX) Social Stream

Featured Post From StockTwits About LCTX

$LCTX I listen to the HC Wainwright presentation this a.m. I am guessing this presentation is a precursor/preparatory presentation, and is a model of what will be presented to the FDA:

1. In the right patients, three out of four head retinal restoration.

2. Even in non-ideal patients, the lineage approach seems to be able to stop geographic atrophy growth.

3. The treatment is durable, i.e. probably just a one time treatment.

Given this approach, our patients will likely include many many non-ideal patients, patients who are already legally blind. I suspect it’s going to be a real challenge to ramp up to be able to treat that many people.

And then there are the ideal patients… The results for these patients are likely to be much better.

It’s going to be important to distinguish between these two groups of patients. Some we can help a little bit. Some we can help a lot.

I want to help as many as possible, ASAP.